Patent · US Active

Agonistic antibodies that bind CD40

US10633444B2 · kind B2 · utility

4Cited by

4References

8Claims

0Family size

Assignee

Celldex Therapeutics, Inc. · US

Inventors

Tibor Keler · Ottsville, US
Joel Goldstein · New Brunswick, US
Laura A. VITALE · Doylestown, US
Lizhen He · Allentown, US
Tom O'NEILL · Hackettstown, US
Andrea Crocker · New Hope, US
Karuna SUNDARAPANDIYAN · Kendall Park, US
Lawrence J. Thomas · Easton, US
Jenifer WIDGER · Alpha, US

Key dates

Filing date	Apr 5, 2019
Grant date	Apr 28, 2020
Priority date	—
Expiry date	Apr 5, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.